Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the PEG ratio high or low?
The PEG ratio of 0.05 is 96% below its 5-year average of 1.32, near the low end of its 5-year range (0.05–2.74).
As of the fiscal period ended Wednesday, December 31, 2025.
Reported annual fiscal-period values; no daily interpolation.
PEG RATIO
0.05
PEG RATIO AVG TTM
N/A
PEG RATIO AVG 3Y
1.65
PEG RATIO AVG 5Y
1.32
PEG RATIO AVG 10Y
N/A
PEG RATIO AVG 15Y
N/A
PEG RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-96.98%
CURRENT VS 5Y AVG
-96.23%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
1.82
median of 49 covered companies
CURRENT VS SECTOR MEDIAN
-97.25%
vs the sector median at left
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TransMedics Group, Inc. (TMDX) | $2.79B | 0.05 | N/A | 1.65 | 1.32 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.86B | N/A | 0.12 | 0.27 | 0.46 |
| Teladoc Health, Inc. (TDOC)vs › | $1.22B | N/A | 0.08 | 0.12 | 0.31 |
| Shoulder Innovations, Inc. (SI)vs › | $470.55M | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $441.49M | N/A | 2.52 | 3.04 | 2.90 |
| 23andMe Holding Co. (ME)vs › | $15.31M | N/A | 0.00 | 0.00 | 0.31 |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.17B | N/A | 0.84 | 0.69 | 0.69 |
| Oscar Health, Inc. (OSCR)vs › | $7.88B | N/A | 0.01 | 0.07 | 0.12 |
| Tempus AI, Inc. (TEM)vs › | $8.24B | N/A | 0.60 | 1.25 | 1.25 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.99B | N/A | 0.10 | 0.17 | 0.14 |
PEG Ratio
0.05
P/E Ratio
18.7
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PEG RATIO |
|---|---|
| 2025-12-31 | 0.05 |
| 2023-12-31 | 2.74 |
| 2022-12-31 | 2.17 |
| 2020-12-31 | 0.34 |
| 2018-12-31 | 1.25 |
| 2017-12-31 | 1.17 |
